Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146029
Status:
TERMINATED
Last Update Posted:
2008-03-26
First Post:
2005-09-01
Brief Title:
Companion Pharmacogenetic Study to UMCC 99009901
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Patients who participated in UMCC 99009901 Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer | View |